comparemela.com

Latest Breaking News On - Hers health - Page 5 : comparemela.com

Citigroup Lowers Hims & Hers Health (NYSE:HIMS) to Neutral

Citigroup cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm currently has $20.00 target price on the stock, up from their prior target price of $16.00. A number of other research […]

Citigroup Downgrades Hims & Hers Health (NYSE:HIMS) to Neutral

Citigroup downgraded shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to a neutral rating in a report published on Wednesday, MarketBeat.com reports. Citigroup currently has $20.00 price target on the stock, up from their previous price target of $16.00. Several other equities analysts have also issued reports on HIMS. […]

Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon

The search for the next GLP-1 drugs that will be blockbuster winners during the next market cycle is on, and here are three contenders.

The Ultimate Growth Stock to Buy With $20 Right Now

I challenge you to name another $20 stock with more long-term potential.

What Does America s Confusion About The Economy Mean For Business?

What Does America s Confusion About The Economy Mean For Business?
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.